Flow cytometry-based high-throughput RNAi screening for miRNAs regulating MHC class II HLA-DR surface expression

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Human Leukocyte Antigen-DR (HLA-DR) is a crucial MHC-II molecule on antigen-presenting cells (APCs) involved in initiating immune responses.
• Reduced HLA-DR expression on leukocytes in immunocompromised patients correlates with disease severity and survival rates, but regulatory mechanisms are unclear.
• MicroRNAs (miRNAs) are known regulators of immune system development and function, suggesting a potential role in HLA-DR expression.

Purpose of the Study:

• To identify specific microRNAs (miRNAs) that upregulate or downregulate the surface expression of HLA-DR.
• To investigate the regulatory mechanisms of HLA-DR expression mediated by miRNAs.
• To explore potential clinical applications of miRNA-based regulation of HLA-DR.

Main Methods:

• High-throughput miRNA screening using flow cytometry in a human melanoma cell line (MelJuSo) engineered for stable HLA-DR expression.
• Validation of identified miRNA effects on both HLA-DR protein and mRNA levels.
• In-silico analysis for predicting miRNA-mRNA interactions and proposing gene regulatory networks.

Main Results:

• Identification of the top ten miRNA upregulators and top five miRNA downregulators of surface HLA-DR expression.
• Experimental verification confirmed the regulatory effects of selected miRNAs on HLA-DR at both protein and mRNA levels.
• Computational predictions provided insights into the functional interactions between identified miRNAs and their target genes involved in HLA-DR regulation.

Conclusions:

• MicroRNAs play a significant role in modulating HLA-DR expression.
• The study provides a foundation for understanding miRNA-mediated regulation of HLA-DR in physiological and pathological contexts.
• Findings may inform the development of novel therapeutic strategies targeting immune responses in various diseases.